Skip to main content

Hela-DFO treated (0.5mM, 24h) Nuclear Lysate. View our extensive range of validated lysates from normal and diseased human, mouse and rat tissue.

Be the first to review this product! Submit a review

Images

Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (AB180880), expandable thumbnail
  • Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (AB180880), expandable thumbnail
  • Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (AB180880), expandable thumbnail
  • Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (AB180880), expandable thumbnail

Publications

Key facts

Cell type
HeLa
Species or organism
Human
Tissue
Cervix
Form
Liquid

Recommended products

Hela-DFO treated (0.5mM, 24h) Nuclear Lysate. View our extensive range of validated lysates from normal and diseased human, mouse and rat tissue.

Key facts

Cell type
HeLa
Form
Liquid
Disease
Adenocarcinoma
Concentration
Loading...

Cell culture

Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female

Storage

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Notes

We recommend aliquoting the extracts into single use fractions and then
storing them at -80°C.

The cells were treated for 24 hours with a 0.5mM solution of Deferoxamine (DFO).
DFO is used as a hypoxia-mimetic agent to stabilize Hypoxia Inducible Factor 1 (HIF-1). DFO stabilizes HIF-1 through the inhibition of Prolyl Hydroxylases (PHDs) which target HIF-1 through degradation. The mechanism of DFO inhibition is likely through the chelation of Fe2+ bound to the active site of PHD which is required for enzymatic activity.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

4 product images

  • Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880), expandable thumbnail

    Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)

  • Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880), expandable thumbnail

    Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)

    We recommend using 5% milk in TBST as the blocking agent, decreasing to 2% milk in TBST during primary and secondary antibody incubation.

    Blots were developed with Goat Anti-Mouse IgG H&L (HRP) preadsorbed (Goat Anti-Mouse IgG H&L (HRP) preadsorbed ab97040) secondary antibody

    All lanes: Western blot - Anti-HIF-1 alpha antibody [H1alpha67] (Anti-HIF-1 alpha antibody [H1alpha67] ab1) at 5 µg/mL

    Lane 1: Western blot - HeLa nuclear extract lysate (HeLa nuclear extract lysate ab150036) at 40 µg

    Lane 2: Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880) at 40 µg

    Lane 3: HeLa nuclear control at 40 µg

    Lane 4: HeLa nuclear DFO treated at 40 µg

    Lane 5: Western blot - Recombinant Human HIF-1 alpha protein (Recombinant Human HIF-1 alpha protein ab154478) at 0.001 µg

    Secondary

    All lanes: Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (Goat Anti-Mouse IgG H&L (HRP) preadsorbed ab97040) at 1/10000 dilution

    Performed under reducing conditions.

    Predicted band size: 92 kDa

    Exposure time: 20min

  • Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880), expandable thumbnail

    Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)

  • Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880), expandable thumbnail

    Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880)

    Abcam recommends using 5% milk as the blocking agent, decreasing to 2% milk during primary and secondary incubation. Abcam welcomes customer feedback and would appreciate any comments regarding this product and the data presented above.

    All lanes: Western blot - Anti-HIF-1 alpha antibody [EP1215Y] (Anti-HIF-1 alpha antibody [EP1215Y] ab51608) at 1/2000 dilution

    Lane 1: Western blot - HeLa nuclear extract lysate (HeLa nuclear extract lysate ab150036) at 40 µg

    Lane 2: Western blot - Hela-DFO treated (0.5mM, 24h) Nuclear Lysate (ab180880) at 40 µg

    Secondary

    All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/10000 dilution

    Developed using the ECL technique.

    Performed under reducing conditions.

    Predicted band size: 92 kDa

    Observed band size: 110 kDa

    Exposure time: 8min

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com